SCHEMBL3482678

SCHEMBL3482678

CCCCOC(CC)N1C(=O)C=CC1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MGLL Q99685 6/20 0.39
PTGS1 P23219 3/20 0.39
PTGS2 P35354 3/20 0.39
FAAH O00519 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.36
LMNA P02545 2/20 0.34
ESR1 P03372 2/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2D6 P10635 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CYP2C19 P33261 1/20 0.34
NR1H2 P55055 1/20 0.34
RNASEL Q05823 1/20 0.34
ALDH1A1 P00352 3/20 0.33
MAPT P10636 2/20 0.33
GMNN O75496 1/20 0.33
THPO P40225 1/20 0.33
BLM P54132 1/20 0.33
PMP22 Q01453 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4960263 0.83 MGLL (0.39) MGLLPTGS1PTGS2FAAHLMNA
SCHEMBL28884160 0.80 SMN1; SMN2 (0.47) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL4961164 0.75 MGLL (0.43) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL9734841 0.72 MGLL (0.37) MGLLPTGS1PTGS2FAAHLMNA
SCHEMBL4957720 0.72 MGLL (0.37) MGLLPTGS1PTGS2FAAHLMNA
SCHEMBL11649166 0.71 MGLL (0.39) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL5160676 0.71 TSHR (0.40) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL3482676 0.70 MGLL (0.38) MGLLPTGS1PTGS2FAAHSMN1; SMN2
SCHEMBL5166313 0.69 ESR1 (0.42) SMN1; SMN2LMNAESR1CYP1A2CYP2D6
SCHEMBL24692227 0.68 MGLL (0.42) MGLLPTGS1PTGS2FAAHSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8420764-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2013-04-16 US disclosed
US-8236917-B2 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2012-08-07 US disclosed
US-20120178894-A1 COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER INAGAKI JYUN-ICHI (JP) 2012-07-12 US disclosed
US-20100240855-A1 Compound having silsesquioxane skeleton and its polymer JNC CORPORATION (JP) 2010-09-23 US disclosed
US-7705105-B2 A cyclic polymer of silsesquioxane skeleton with side chains formed byhydrosilation of an unsaturated end group containing an active polymerfunctional group; polyimidesiloxane copolymers; polyestersiloxane copolymers; high molecular weight; thin films; strength; heat resistance;waterproofing; CHISSO PETROCHEMICAL CORPORATION (JP) 2010-04-27 US disclosed
US-20070190344-A1 Verification of translation JNC CORPORATION (JP) 2007-08-16 US disclosed
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer CHISSO CORPORATION (JP) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009982-A1 Compound having silsesquioxane skeleton and its polymer C1S, H1-4, H1-0 MGLL 4700/4885PTGS1 1102/4885PTGS2 2594/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.